Lotrel News
Teva Fourth-Quarter Profit Jumps on Protonix Copies (Update3) - Bloomberg
The drugmaker used this ``at risk'' strategy when it released Protonix in December and a version of Novartis AG's Lotrel heart medicine in May. ...
Market Spotlight: Generic Drugs - CNNMoney.com
A similar discount currently exists for Lotrel, a blood pressure drug made by Novartis (NYSE:NVS) , for which Teva enjoys market exclusivity with a generic. ...
Medco profit slips, but tops forecasts - The Star-Ledger - NJ.com
Generic versions of the in somnia treatment Ambien and the blood pressure drug Lotrel added $14.7 billion to revenue during all of 2007, the company said. ...
Market Spotlight: Generic Drugs - Forbes
A similar discount currently exists for Lotrel, a blood pressure drug made by Novartis (nyse: NVS - news - people ), for which Teva enjoys market ...
Novartis' ex-chief does U-turn back to J&J - The Star-Ledger - NJ.com
Between 2006 and 2007, generic competition in the United States shaved a cumulative $1 billion off sales of the high blood pressure drug Lotrel, ...
Novartis 4Q net profit falls 45 percent - Jordan Falls News
... drug Zelnorm from the US market and generic competition for some of its best-selling products, including hypertension drug Lotrel, squeezed results. ...
Teva Reports Fourth Quarter and Full Year 2007 Results - WELT ONLINE
... Neurontin®, Lotrel® Famvir®, and Protonix®, Teva's ability to successfully develop and commercialize additional pharmaceutical products, ...
Teva Raises Guidance After Fourth-Quarter Net Jumps (Update1) - Bloomberg
Teva used this ``at risk'' strategy when it released Protonix and a version of Novartis AG's Lotrel heart medicine. ``Lotrel still has no competition, ...
Analysts expect aggressive guidance from Teva - Globes
Erez also believes that Teva will report 8% growth for the fourth quarter, mostly thanks to its marketing exclusivity for generic Lotrel, the initial launch ...
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg ... - FOXBusiness
... Neurontin(R), Lotrel(R) Famvir(R) and Protonix(R), Teva's ability to successfully develop and commercialize additional pharmaceutical products, ...
Lotrel RSS Feed